KELLY GOODENOUGH: Open Payments
NPI 1376889238 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 50 payments from 14 companies in 2025. Trend: 2023 $399 · 2024 $1,164 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $253 |
| PFIZER INC. | 13 | $189 |
| Exact Sciences Corporation | 4 | $88 |
| Lilly USA, LLC | 4 | $77 |
| Amgen Inc. | 4 | $75 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
Products named: The Cologuard Plus Collection Kit, ELIQUIS, MOUNJARO, NURTEC ODT, Ozempic, Rybelsus, Wegovy, AIRSUPRA.
Industry payments across DE — which companies pay providers there.
